are sent to higher brain areas to create percepts. It was exactly what I was looking for and I managed to wangle my way into his lab without any formal training in neuroscience or biology.
Who were your early infl uences?
My parents encouraged me to be curious and gave me the freedom to explore the world and discover my interests with the certainty that they would catch me if I fell. My brother's academic successes motivated me to study hard, lest I be the also-ran in the family. Another key infl uence was my PhD advisor Markus Meister, a rigorous, deep, and critical thinker who taught me by example to question assumptions and challenge dogmas. He encouraged me to come up with my own questions and let me fail and succeed on my own terms.
If you had to choose a different fi eld of biology, what would it be?
Probably cancer biology. I started reading up on it when my father was diagnosed with late stage stomach cancer. I was able to explain to him the biology behind the disease and ways in which we could beat the diagnosis. The mere possibility of directly contributing to transformative new therapies that extend patient lives and alleviate suffering lends cancer research a dimension that my current work lacks, and one that I would fi nd rewarding and sustaining. and become a theatre director. Again, fear of mediocrity kept me far away. I tried my hand at journalism, spending two years after graduation as a reporter and art critic. I was initially thrilled to go to theatre and fi lm festivals and meet and interview artists, but the novelty soon wore off and the decadence and evanescence of the whole endeavor caught up with me. It made me realize how much I value the lasting and meaningful contributions one can make as a scientist.
Do you have a scientifi c hero?
Did your time as a journalist help you become a better scientist? I think of scientists as investigative journalists that work with experimental data as their primary 'source'. We too are looking to break a good story. Once we have the outlines of one, we gather more information and try to present our 'scoop' in a way that engages our audience. It's fundamentally the same process whether the 'story' is about science, art, or politics. Developing narratives for our experimental results is one of the more creative and enjoyable aspects of my work, and one for which my experience with journalism may indeed be helpful.
Do you have a favourite conference?
There are many stimulating conferences, but the synergy between great science and fi rst-rate skiing is hard to beat. There is something about the mountains that catalyses scientifi c thought and dialogue, and I know of many creative experiments that were conceived in ski lifts. The Winter Neuroscience conference in Sölden is my favourite, with the Cosyne workshops in Utah a close second. Sadly, large conferences give me headaches, so I tend to avoid them. Do you feel a push towards more applied science, and if so, how does that affect your own work? I would love for my science to be more applied. The best chance of that is if
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R1156 Current Biology 25, R1151-R1165, December 21, 2015 ©2015 Elsevier Ltd All rights reserved we extend the notion of 'applied' t o include informing the general public about the mechanistic underpinnings of thoughts, feelings, perceptions, and actions. Just like art, literature, and philosophy, neuroscience can give us a deeper understanding of the human condition. To realize that potential, we need to popularize our work without trivializing it. We need a Feynmann of neuroscience.
What is your biggest lamentation about how science is conducted today? Rather than being a collective and collaborative quest to understand the truth about ourselves and the world around us, science has become a bit too much like Monopoly, a zero-sum game with winners and losers, haves and have-nots. The winner is the one who racks up the most Nature and Science papers, and gets the most grants and awards. To succeed in science these days you have to understand and master the intricacies of this game, a realization that can be demoralizing to many who enter science with high-minded ideals and aspirations. I have seen many brilliant students quit science because they are unwilling to engage in the politics and gamesmanship of our enterprise. I think the key is to recognize the rules of the game and play it with decency, while maintaining a playful curiosity-driven approach to science. It may not be easy, but with good mentoring, some luck and shrewdness it can be done as attested by the many great scientists working today. Do you believe there is a need for more crosstalk between biological disciplines? I would welcome more crosstalk with theorists. Biological data are exploding in quantity and complexity and we need smart people with quantitative skills to make sense of it all and extract organizing principles. My most stimulating collaborations have been with theorists whose minds are uncontaminated by entrenched assumptions about what our data should be telling us. More generally, discussions with smart and inquisitive outsiders have always been a great source of new insights, ideas, and research directions.
Any strong views on social media and science -for example, the role of science blogs in critiquing published papers? Science functions best when it is dialectic and we should all welcome thoughtful criticism of our work. Science blogs are great forums for this. Some people have a great taste in science and a critical mind to go with it, and I would love to read their opinions on the latest papers. But quality commentary takes signifi cant time and effort and is a rather rare commodity. More common are twitterlevel outbursts, which tend to be far less thoughtful and constructive and often end up hampering rather than catalysing meaningful scientifi c discourse.
Do you think there is too much emphasis on big data-gathering collaborations as opposed to hypothesis-driven research by small groups? That's an interesting and timely question. The BRAIN initiative in the US is focused on developing new tools for data gathering. The human brain project in Europe is deemed premature because of lack of data. There is a hunger for data, data, and more data, but to what end? There seems to be a notion that if only we could record from more neurons, identify more cell types, map more connections, the mystery of the brain would magically reveal itself. John Hopfi eld warned against this fallacy more than fi fteen years ago, when he issued a challenge to neuroscientists to think deeply about the data they have, rather than spend time and resources collecting more. His advice seems largely to have fallen on deaf ears. On the other hand, large projects must necessarily benefi t the community as a whole and focusing on tool development is an easy way to reach consensus and set achievable, if incremental, goals. The optimistic viewpoint is that these large-scale investments will facilitate rather than stymie hypothesis-driven research, which will continue to be the main engine for progress in neuroscience.
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TPX2

Pat Wadsworth
What is TPX2? TPX2 is a microtubule-associated protein that is required for mitotic spindle assembly and function. TPX2 has a nuclear localization sequence (NLS) and is nuclear-localized during interphase; in mitosis it localizes to spindle microtubules, with an enrichment toward the spindle poles (Figure 1 ).
Where does the name TPX2 come from? TPX2 was first characterized as a factor in mitotic egg extracts that was required for the dyneindependent localization of a plus-end directed kinesin, Xkpl2, to the spindle poles. Based on these experiments, the protein was named Targeting Protein for Xklp2, or TPX2. Ironically, although we have learned a great deal about TPX2 since 1998, we still do not fully understand how TPX2, a microtubule-associated protein, actually targets Xklp2!
What does TPX2 do in mitosis?
TPX2 is probably best known for its role in stimulating microtubule assembly during mitotic spindle formation. For many years, how microtubule nucleation occurs in cells that lack centrosomes baffl ed researchers. A key advance was the demonstration that the small GTPase Ran is locally activated near chromosomes, and that active Ran could promote aster and spindle formation in egg extracts that lacked centrosomes or chromosomes. However, Ran doesn't act directly on microtubules -it binds importins  and  and relieves their inhibitory effect on NLScontaining proteins, called spindle assembly factors. Following activation, spindle assembly factors promote microtubule formation near chromosomes. Recent work further shows that TPX2 is required for the formation of branched microtubules, a process that requires both the -tubulin ring complex and a
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